What is Australia’s potential new COVID treatment? Half a million doses of the oral antiviral candidate could become available from next year, pending TGA approval.
‘Absolutely heartbreaking’: GP forced to throw out hundreds of expired COVID vaccines Plans have been announced to send unused doses overseas, but an absence of forward planning is resulting in wastage.
COVID-19 vaccination reduces household transmission up to 97% The new research findings also appear to be reflected by the recent downward trend in Australian locally acquired cases, a former World Health Organization epidemiologist says.
Immunocompromised require third COVID vaccine dose: ATAGI The additional dose is considered part of the primary regimen and is intended to generate an immune response equivalent to the general population.
TGA monitoring overseas Moderna recommendations Several countries have limited the use of the mRNA vaccine in younger people, but there is no sign Australia will institute a similar pause.
GPs could soon have an antiviral pill to treat COVID-19 A new oral treatment reduces the risk of hospitalisation and death due to COVID by 50%, research suggests.
Adolescents at most risk of developing myocarditis: TGA Myocarditis rates related to the Pfizer vaccine been released, while the Moderna vaccine has been included in the safety report for the first time.
Pfizer for all: Over-60s eligible nationwide from October Increasing supply means all Australians 12 and older will soon have access to mRNA COVID-19 vaccines.
Government moves to ease concerns over next month’s Pfizer supply The Federal Government says Pfizer has confirmed it will meet its scheduled delivery following reports of a potential shortfall.
One in a million chance of death following AstraZeneca jab: TGA By contrast, Australians aged 60 and over – for whom AstraZeneca is preferred – have a nearly one in 10 chance of dying from COVID.